Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: A meta-analysis

Liver International

Volumn 30, Issue 5, 2010, Pages 741-749

  Wang, Wei ^a   Shi, Jian ^a   Xie, Wei Fen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Percutaneous ablation

Indexed keywords

ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; META ANALYSIS; MONOTHERAPY; OUTCOMES RESEARCH; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; SYSTEMATIC REVIEW;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77954352223     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02221.x     Document Type: Article

References (29)

1. Colombo M. Screening and diagnosis of hepatocellular carcinoma. Liver Int 2009, 29((Suppl. 1)):143.
2. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003, 37:429-42.
3. Shiina S, Teratani T, Obi S. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122-30.
4. Brunello F, Veltri A, Carucci P. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 2008, 43:727-35.
5. Jansen MC, van Hillegersberg R, Chamuleau RA. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005, 31:331-47.
6. Chua TC, Liauw W, Saxena A. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int 2009, 30:166-74.
7. Veltri A, Moretto P, Doriguzzi A. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 2006, 16:661-9.
8. Gasparini D, Sponza M, Marzio A. Combined treatment TACE and RF ablation, in HCC: preliminary results. Radiol Med 2002, 104:412-20.
9. Kirikoshi H, Saito S, Yoneda M. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy of hepatocellular carcinoma. Hepatol Res 2009, 39:553-62.
10. Becker G, Soezgen T, Olschewski M. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005, 11:6104-9.
11. Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996, 17:1-12.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-88.
13. Wu F, Wang ZB, Chen WZ. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial emobolization. Radiology 2005, 235:659-67.
14. Li XY, Yang LZ. Analysis of transcatheter arterial chemoembolization combined with percutaneous ethanol injection for hepatoma. Chin J Interv Imaging Ther 2007, 4:269-72.
15. Bartolozzi C, Lencioni R, Caramella D. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995, 197:812-8.
16. Wu PH, Li L, Zhang YM. Transcathrter arterial chemoembolization combined with CT-guided percutaneous intratumoral injection of lipiodol-ethanol for the treatment of hepatocellular carcinoma. Chin J Oncol 1998, 5:391-3.
17. Koda M, Murawaki Y, Mitsuda A. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma. Cancer 2001, 92:1516-24.
18. Xu GH, Wen HC, Li ZW. Evaluation of hepatic chemoembolization and percutaneous ethanol injection in the treatment of HCC. Chin J Radiology 2002, 1:66-8.
19. Francesco S, Stella A, Gambacorta D. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results. Radio Med 2004, 108:356-71.
20. Aikata H, Shirakawa H, Takaki S. Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma. Hepatology 2006, 4((Suppl.)):A487.
21. Wang YB, Chen MH, Yan K. Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone. Qual Life Res 2007, 16:389-97.
22. Yang P, Liang MH, Zhang YX. Clinical application of a combination therapy of Lentinan, multi-electrode RFA and TACE in HCC. Adv Ther 2008, 25:787-94.
23. Shibata T, Isoda H, Hirokawa Y. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009, 252:905-13.
24. Yamamoto K, Masuzawa M, Kato M. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Sem Oncol 1997, 24(Suppl. 6):50-5.
25. Goldberg SN, Girnan GD, Lukyanov AN. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002, 222:797-804.
26. Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006, 238:346-53.
27. Komorizono Y, Oketani M, Sako K. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003, 97:1253-62.
28. Nakazawa T, Kokubu S, Shibuya A. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR 2007, 188:480-8.
29. Cho YK, Kim JK, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009, 49:453-9.